Skip to main content

Jenny Chen, PhD


[email protected]



Jenny is a versatile life sciences patent attorney and IP adviser who represents US and international clients in a wide array of patent-related matters. She draws on an in-depth understanding of her clients’ industries and technology to help them protect innovations involving antibodies, cell therapies, gene editing, small molecule therapeutics, pharmaceutical formulations, and diagnostic agents and assays.

Jenny’s practice encompasses US and international patent prosecution, IP due diligence for transactions, clearance analyses, licensing, opinion work, and post-grant proceedings. She has extensive experience with providing strategic counseling on the life-cycle management of both biological and small molecule products.

Prior to joining Mintz, Jenny practiced patent law for more than 15 years, most recently as a partner at an international law firm.

Earlier in her career, as a Harvard Medical School postdoctoral fellow, she worked in the laboratory of Dr. David Hafler at Brigham & Women’s Hospital. In that role, she conducted research on T cell activity in autoimmune diseases such as Type I diabetes.


  • Built global patent portfolios covering an antibody product for a multinational pharmaceutical company that obtained marketing approval in various countries.
  • Built global patent portfolios covering cell therapy products for a leading gene editing company.
  • Conducted a clearance analysis in connection with a multinational pharmaceutical company’s biosimilar drug development.
  • Conducted due diligence studies in connection with various biotech transactions.
  • Assisted a leading academic institution in securing patent protection for a diagnostic test expected to be used on millions of patients to ascertain risks for adverse drug reactions.
  • Demonstrated continuous diligence over an 11-month period in an interference proceeding for a publicly traded biotechnology company.
Read less


How Can the Updated USPTO Guidance on Determining Obviousness Help You?

March 7, 2024 | Blog | By Peter Hecker, PhD, Jenny Chen, PhD, Ken Jenkins, Christina Sperry

Read more
Read less

News & Press

Press Release Thumbnail
Mintz proudly announced the election of 13 attorneys to Members and the addition of a record-setting 22 new lateral Members in 2023, with 11 Partners in the newly opened Toronto office. This diverse group strengthens Mintz’s core areas, spanning Commercial and IP Litigation, Life Sciences, Tech, Private Equity, and Energy & Sustainability. The elevated Members and new lateral additions bring invaluable expertise to help clients navigate complex legal landscapes.
News Thumbnail
Law360 detailed the arrival of IP Partner Y. Jenny Chen PhD to Mintz’s life sciences practice in Boston.
Press Release Thumbnail
BOSTON – Y. Jenny Chen, PhD has joined Mintz as a Member in the firm’s highly-regarded Intellectual Property (IP) practice, adding further expertise and depth to the firm’s life sciences offering.
Read less

Events & Speaking


Best Practices in Patent Drafting and Application

LSPN North America–Spring Conference

Event Reference Image
Read less

Recognition & Awards

  • The Legal 500 United States (2021)

  • Best Lawyers in America: Patent Law (2022 – 2023)

  • Massachusetts Super Lawyers: Rising Star – Intellectual Property (2014 – 2016)

  • Identified in the IAM Patent 1000 for Prosecution (2021– 2023)

Read less


  • Member, American Bar Association
  • Member, American Intellectual Property Law Association
  • Member, Boston Patent Law Association
Read less